HK Stock MarketDetailed Quotes

02126 JW THERAP-B

Watchlist
  • 1.920
  • +0.020+1.05%
Market Closed May 3 16:09 CST
795.57MMarket Cap-938P/E (TTM)

JW THERAP-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
19.32%173.86M
32.93%87.74M
373.10%145.7M
--66.01M
--30.8M
----
----
----
----
----
Operating income
19.32%173.86M
32.93%87.74M
373.10%145.7M
66.01M
30.8M
Cost of sales
1.51%-85.64M
-0.12%-42.93M
-299.71%-86.95M
---42.88M
---21.75M
----
----
----
----
----
Operating expenses
1.51%-85.64M
-0.12%-42.93M
-299.71%-86.95M
-42.88M
-21.75M
Gross profit
50.14%88.22M
93.74%44.81M
549.60%58.76M
23.13M
9.05M
Selling expenses
40.70%-113.2M
28.75%-60.17M
-11.80%-190.88M
-82.88%-84.45M
-1,186.80%-170.73M
---46.18M
---13.27M
----
----
----
Administrative expenses
22.09%-140.05M
13.45%-78.69M
10.80%-179.76M
13.49%-90.92M
12.87%-201.52M
-29.74%-105.1M
-217.31%-231.29M
-216.98%-81.01M
-76.67%-72.89M
---25.56M
Research and development expenses
-1.42%-413.62M
-10.54%-216.53M
1.59%-407.82M
-5.59%-195.89M
-84.00%-414.4M
-125.50%-185.51M
-65.47%-225.22M
-51.63%-82.27M
-79.11%-136.11M
---54.26M
Special items of operating profit
-54.92%-210.97M
5.36%-79.34M
-835.36%-136.18M
-2,713.15%-83.83M
-36.01%18.52M
-35.35%3.21M
570.19%28.94M
1,793.52%4.96M
-13.92%4.32M
---293K
Operating profit
7.74%-789.61M
9.73%-389.92M
-12.75%-855.88M
-29.49%-431.96M
-72.19%-759.08M
-110.71%-333.58M
-115.38%-440.84M
-97.63%-158.31M
-82.37%-204.68M
-80.11M
Financing income
105.78%34.03M
179.41%15.09M
99.31%16.54M
179.21%5.4M
141.09%8.3M
1,434.92%1.93M
89.07%3.44M
-18.71%126K
66.67%1.82M
--155K
Financing cost
-82.92%-12.42M
-106.85%-5.58M
-152.12%-6.79M
-402.61%-2.7M
-249.61%-2.69M
-85.17%-537K
43.01%-770K
67.19%-290K
53.69%-1.35M
---884K
Special items of earning before tax
----
----
----
----
104.17%51.15M
110.47%51.49M
-185.67%-1.23B
-77.43%-491.55M
-170.59%-429.05M
---277.04M
Earning before tax
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
-132.29%-633.26M
-357.87M
After-tax profit from continuing operations
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
-132.29%-633.26M
-357.87M
Earning after tax
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
-132.29%-633.26M
-357.87M
Profit attributable to shareholders
9.23%-768M
11.38%-380.42M
-20.48%-846.14M
-52.93%-429.25M
57.79%-702.33M
56.82%-280.7M
-162.74%-1.66B
-81.64%-650.03M
-132.29%-633.26M
-357.87M
Basic earnings per share
9.22%-1.87
11.43%-0.93
-17.05%-2.06
-47.89%-1.05
86.04%-1.76
92.87%-0.71
-29.47%-12.61
-80.76%-9.96
-132.46%-9.74
-5.51
Diluted earnings per share
9.22%-1.87
11.43%-0.93
-17.05%-2.06
-47.89%-1.05
86.04%-1.76
92.87%-0.71
-29.47%-12.61
-80.76%-9.96
-132.46%-9.74
-5.51
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 19.32%173.86M32.93%87.74M373.10%145.7M--66.01M--30.8M--------------------
Operating income 19.32%173.86M32.93%87.74M373.10%145.7M66.01M30.8M
Cost of sales 1.51%-85.64M-0.12%-42.93M-299.71%-86.95M---42.88M---21.75M--------------------
Operating expenses 1.51%-85.64M-0.12%-42.93M-299.71%-86.95M-42.88M-21.75M
Gross profit 50.14%88.22M93.74%44.81M549.60%58.76M23.13M9.05M
Selling expenses 40.70%-113.2M28.75%-60.17M-11.80%-190.88M-82.88%-84.45M-1,186.80%-170.73M---46.18M---13.27M------------
Administrative expenses 22.09%-140.05M13.45%-78.69M10.80%-179.76M13.49%-90.92M12.87%-201.52M-29.74%-105.1M-217.31%-231.29M-216.98%-81.01M-76.67%-72.89M---25.56M
Research and development expenses -1.42%-413.62M-10.54%-216.53M1.59%-407.82M-5.59%-195.89M-84.00%-414.4M-125.50%-185.51M-65.47%-225.22M-51.63%-82.27M-79.11%-136.11M---54.26M
Special items of operating profit -54.92%-210.97M5.36%-79.34M-835.36%-136.18M-2,713.15%-83.83M-36.01%18.52M-35.35%3.21M570.19%28.94M1,793.52%4.96M-13.92%4.32M---293K
Operating profit 7.74%-789.61M9.73%-389.92M-12.75%-855.88M-29.49%-431.96M-72.19%-759.08M-110.71%-333.58M-115.38%-440.84M-97.63%-158.31M-82.37%-204.68M-80.11M
Financing income 105.78%34.03M179.41%15.09M99.31%16.54M179.21%5.4M141.09%8.3M1,434.92%1.93M89.07%3.44M-18.71%126K66.67%1.82M--155K
Financing cost -82.92%-12.42M-106.85%-5.58M-152.12%-6.79M-402.61%-2.7M-249.61%-2.69M-85.17%-537K43.01%-770K67.19%-290K53.69%-1.35M---884K
Special items of earning before tax ----------------104.17%51.15M110.47%51.49M-185.67%-1.23B-77.43%-491.55M-170.59%-429.05M---277.04M
Earning before tax 9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M-132.29%-633.26M-357.87M
After-tax profit from continuing operations 9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M-132.29%-633.26M-357.87M
Earning after tax 9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M-132.29%-633.26M-357.87M
Profit attributable to shareholders 9.23%-768M11.38%-380.42M-20.48%-846.14M-52.93%-429.25M57.79%-702.33M56.82%-280.7M-162.74%-1.66B-81.64%-650.03M-132.29%-633.26M-357.87M
Basic earnings per share 9.22%-1.8711.43%-0.93-17.05%-2.06-47.89%-1.0586.04%-1.7692.87%-0.71-29.47%-12.61-80.76%-9.96-132.46%-9.74-5.51
Diluted earnings per share 9.22%-1.8711.43%-0.93-17.05%-2.06-47.89%-1.0586.04%-1.7692.87%-0.71-29.47%-12.61-80.76%-9.96-132.46%-9.74-5.51
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg